PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--STENTYS (Paris: STNT) (FR0010949404 — STNT), a medical technology company commercializing the world’s first and only Self-Apposing® coronary stent, today announces its half-year results for the six months ended June 30, 2015, as approved by the Board meeting of September 17, 2015.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
